TrialBlood cancer journal2017

Alternative splicing discriminates molecular subtypes and has prognostic impact in diffuse large B-cell lymphoma.

S-K Leivonen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.